Michael Nilsson, CEO and founder of AddEvent
Physicians and patients both struggle with the healthcare system’s many idiosyncrasies, albeit in different ways. On the caregiver side, missed appointments are estimated to cost the average solo…
Continue Reading
Health systems across the country continue to sing the praises of AI scribes — celebrating these tools not only for their ability to give clinicians hours back into their days, but also because they…
Continue Reading
Absci, a data-first generative AI drug creation company, is partnering with AMD, a semiconductor company, to deploy AMD Instinct accelerators and ROCm software to power vital AI drug discovery workloads, as well as Absci’s…
Continue Reading
What You Should Know:
– Denver Health, an integrated health system and Colorado’s primary safety-net provider has partnered with Nabla, an ambient AI technology for healthcare, to deploy its AI-powered assistant across its network of…
Continue Reading
What You Should Know:
– Iris Telehealth, a leading provider of telepsychiatry services, announced the acquisition of innovaTel, a division of Quartet Health renowned for its expertise in treating complex mental health conditions. Financial details…
Continue Reading
Simon Johns, Director, Medical Information and Marketed Product Safety at IQVIA
The demand for accurate and timely medical information has never been greater. As healthcare providers and patients navigate an increasingly complex landscape of therapies…
Continue Reading
Discover how NextGen Healthcare is using AI to make a real difference for healthcare providers and their patients.In this interview, David Sides, CEO of NextGen, shares insights on how the company is deploying AI…
Continue Reading
The government has announced a new package of AI tools, nicknamed ‘Humphrey’ to streamline the NHS and other public services.
A team of expert AI developers from the Department for Science, Innovation and Technology (DSIT) built…
Revolutionary Phase III Trial Results
Bayer has announced groundbreaking topline results from their Phase III QUANTI studies evaluating gadoquatrane, an innovative gadolinium-based contrast agent (GBCA) for magnetic resonance imaging (MRI). The revolutionary aspect of this…
Glaucoma is the leading cause of irreversible blindness globally. Research indicates a disproportionate impact of glaucoma on racial and ethnic minorities. Existing deep learning models for glaucoma detection might not achieve equitable performance across…
Continue Reading
